BFM
IRMD icon

Boothbay Fund Management’s iRadimed IRMD Stock Holding History

Boothbay Fund Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$655K Buy
+6,802
New +$680K 0.01% 1184
2025
Q4 		– Sell
-3,918
Closed -$279K – 2150
2025
Q3 		$279K Buy
+3,918
New +$261K ﹤0.01% 1485

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boothbay Fund Management's IRMD Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in iRadimed (IRMD) in Q1 2026: 6,802 shares worth $655K. The stake represents 0.01% of the portfolio and ranks #1184 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in IRMD as recently as Q3 2025.

Boothbay Fund Management first reported a position in IRMD in Q3 2025 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Boothbay Fund Management held 6,802 shares of iRadimed worth $655K as of Q1 2026.
  • iRadimed was a new Boothbay Fund Management position in Q1 2026.
  • iRadimed made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1184 holding.
  • Boothbay Fund Management first reported a position in iRadimed in Q3 2025 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.